Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2).

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Experimental Neurology

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.expneurol.2010.01.007PMID 20083106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The protective effects of 15‐deoxy‐Δ‐12,14‐prostaglandin J2 in spinal cord injury

  2008cited by this paper
• TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system

  2008cited by this paper
• Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43.

  2008cited by this paper
• Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia

  2008cited by this paper
• Peroxisome proliferator‐activated receptor‐γ agonists inhibit respiratory syncytial virus‐induced expression of intercellular adhesion molecule‐1 in human lung epithelial cells

  2007cited by this paper
• TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

  2007cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.

  2007cited by this paper
• Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.

  2007cited by this paper
• Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

  2007cited by this paper
• Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43

  2007influential reference
• Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement.

  2007cited by this paper
• 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.

  2007cited by this paper
• Hippocampal sclerosis dementia: a reappraisal

  2007cited by this paper
• TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.

  2007cited by this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression

  2007cited by this paper
• Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam

  2007cited by this paper
• Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in T Lymphocytes

  2007cited by this paper
• A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production.

  2007cited by this paper
• Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ12–14 PGJ2

  2007cited by this paper
• Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006influential reference
• Prostaglandin J2 Alters Pro-survival and Pro-death Gene Expression Patterns and 26 S Proteasome Assembly in Human Neuroblastoma Cells*

  2006cited by this paper
• TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

  2006influential reference
• Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity.

  2005influential reference
• Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.

  2005cited by this paper
• Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2).

  2004cited by this paper
• Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Δ12,14-Prostaglandin J2

  2004cited by this paper
• Peroxisome Proliferator-activated Receptor γ Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor α in MCF-7 Breast Cancer Cells

  2003cited by this paper
• Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons.

  2003cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.

  2003cited by this paper
• Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.

  2002cited by this paper
• 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.

  2002influential reference
• 15-Deoxy-Δ12,14-prostaglandin J2: The endogenous electrophile that induces neuronal apoptosis

  2002influential reference
• Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ

  2002cited by this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.

  2002influential reference
• Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).

  2002cited by this paper
• Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1

  2001cited by this paper
• Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9*

  2001cited by this paper
• 15-Deoxy-Δ12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-γ, induces neuronal apoptosis

  2001cited by this paper
• Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator of CFTR Exon 9*

  2001cited by this paper
• Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

  2001cited by this paper
• 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis.

  2001cited by this paper
• DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.

  2000cited by this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway

  2000cited by this paper
• Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase

  2000cited by this paper
• Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.

  1999cited by this paper
• Inducible cyclooxygenase may have anti-inflammatory properties

  1999cited by this paper
• Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

  1995cited by this paper
• Prostaglandin A2 protein interactions and inhibition of cellular proliferation.

  1995cited by this paper
• Purification and N-terminal sequence of β-trace, a protein abundant in human cerebrospinal fluid.

  1993cited by this paper
• Isolation and amino terminal sequence of beta-trace, a novel protein from human cerebrospinal fluid.

  1991cited by this paper
• Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2.

  1990cited by this paper
• Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved.

  1990cited by this paper
• Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.

  1987cited by this paper
• Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins.

  1985cited by this paper
• Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandins

  1985cited by this paper
• Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.

  1983cited by this paper
• Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution.

  1982influential reference
• Proteins in Normal Cerebrospinal Fluid Not Found in Serum.∗

  1961cited by this paper

• Novel tankyrase inhibitors suppress TDP-43 aggregate formation.

  2020cites this paper
• Targeting TDP‐43 proteinopathy with drugs and drug‐like small molecules

  2020cites this paper
• Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.

  2018cites this paper
• Regulation of the Amyloid Precursor Protein by Prostaglandin J2, A Mediator of Inflammation: Relevance to Alzheimer’s Disease

  2017cites this paper
• Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis.

  2016cites this paper
• Environmental Factors and Amyotrophic Lateral Sclerosis: What Do We Know?

  2015cites this paper
• Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

  2015cites this paper
• Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function.

  2014cites this paper
• Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

  2013cites this paper
• Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation

  2013cites this paper
• Keap1 Is Localized in Neuronal and Glial Cytoplasmic Inclusions in Various Neurodegenerative Diseases

  2013cites this paper
• TDP-43: gumming up neurons through protein-protein and protein-RNA interactions.

  2012cites this paper
• p62/sequestosome 1 binds to TDP‐43 in brains with frontotemporal lobar degeneration with TDP‐43 inclusions

  2012cites this paper
• Redox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking

  2011cites this paper
• Electrophilic eicosanoids: Signaling and targets.

  2011cites this paper
• TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

  2011cites this paper